#Lineage w initial release date update

In parallel, we are advancing our auditory neuron and photoreceptor programs through preclinical development activities which are necessary to support initial clinical testing.

In particular, our efforts have been focused on preparing for OPC1 and VAC2 regulatory interactions to enable their next phases of clinical testing in spinal cord injury and oncology, respectively. “As we continue to position Lineage as a leader in regenerative medicine through the transplant of specific cell types, our focus is on completing the necessary clinical, regulatory and related activities which can create value and reduce risk across our portfolio of five cell transplant assets. During the second quarter this year, we have made progress across multiple functional areas, including clinical, regulatory, and technology transfer activities,” stated Brian M. “We are pleased with the progress on RG6501 (OpRegen) product development under our collaboration with Roche and Genentech. Pacific Time to discuss its second quarter 2022 financial and operating results and to provide a business update. Lineage management will host a conference call and webcast today at 4:30 p.m. Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today reported financial and operating results for the second quarter of 2022. Securities of $72.0 Million as of June 30,Ģ022 Expected to Provide Capital Through Q2 2024ĬARLSBAD, Calif.–(BUSINESS WIRE)–Aug. Expanded Collaboration with Advanced BioMatrixįor HyStem ® Cell Drug Delivery Technology.Regulatory Interactions for OPC1 and VAC2 Completed Key Activities to Support Planned.Results in Journal of Neurosurgery: Spine

Published OPC1 Phase 1/2a Clinical Study.Research, News, and Market Data on Lineage Cell Therapeuticsĭevelopment in Partnership with Roche and Genentech

#Lineage w initial release date update

Lineage Cell Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Update